{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:12:02Z","timestamp":1791461522493,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201508510083"],"award-info":[{"award-number":["201508510083"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ejpb.2018.07.016","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T02:39:27Z","timestamp":1532140767000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Organic acids as co-formers for co-amorphous systems \u2013 Influence of variation in molar ratio on the physicochemical properties of the co-amorphous systems"],"prefix":"10.1016","volume":"131","author":[{"given":"Wenqi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korbinian","family":"L\u00f6bmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Grohganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.07.016_b0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14227\/DT160209P47","article-title":"Commentary: towards physicorelevant dissolution testing: the importance of solid-state analysis in dissolution","volume":"16","author":"Aaltonen","year":"2009","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.ejpb.2018.07.016_b0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1773-2247(13)50057-8","article-title":"Amorphous drugs and dosage forms","volume":"23","author":"Grohganz","year":"2013","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2018.07.016_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/js9601896","article-title":"Characteristics and significance of the amorphous state in pharmaceutical systems","volume":"86","author":"Hancock","year":"1997","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejpb.2018.07.016_b0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2015.12.009","article-title":"Recent advances in co-amorphous drug formulations","volume":"100","author":"Dengale","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.07.016_b0025","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/mp2002973","article-title":"Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen","volume":"8","author":"L\u00f6bmann","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejpb.2013.03.014","article-title":"Amino acids as co-amorphous stabilizers for poorly water soluble drugs\u2013Part 1: preparation, stability and dissolution enhancement","volume":"85","author":"L\u00f6bmann","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0035","article-title":"Co-amorphous drug systems of carbamazepine: intrinsic dissolution rate improvements","volume":"6","author":"Asare-Addo","year":"2017","journal-title":"Int. J. Basic Med. Sci. Pharm. (IJBMSP)"},{"key":"10.1016\/j.ejpb.2018.07.016_b0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijpharm.2013.04.032","article-title":"Coamorphous repaglinide\u2013saccharin with enhanced dissolution","volume":"450","author":"Gao","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-5173(02)00195-3","article-title":"Physicochemical properties of amorphous salt of cimetidine and diflunisal system","volume":"241","author":"Yamamura","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0939-6411(00)00060-6","article-title":"Physicochemical properties of amorphous precipitates of cimetidine\u2013indomethacin binary system","volume":"49","author":"Yamamura","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpharm.2012.05.016","article-title":"A theoretical and spectroscopic study of co-amorphous naproxen and indomethacin","volume":"453","author":"L\u00f6bmann","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2011.10.046","article-title":"Cocrystallization and amorphization induced by drug\u2013excipient interaction improves the physical properties of acyclovir","volume":"422","author":"Masuda","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0065","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejpb.2013.03.026","article-title":"Amino acids as co-amorphous stabilizers for poorly water-soluble drugs\u2013Part 2: molecular interactions","volume":"85","author":"L\u00f6bmann","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2009.01.027","article-title":"Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: amorphous naproxen\u2013cimetidine mixtures prepared by mechanical activation","volume":"136","author":"Alles\u00f8","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.07.016_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejps.2016.08.022","article-title":"Development of a screening method for co-amorphous formulations of drugs and amino acids","volume":"95","author":"Kasten","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.07.016_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2018.04.014","article-title":"The use of molecular descriptors in the development of co-amorphous formulations","author":"Meng-Lund","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.07.016_b0085","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17425247.2016.1198770","article-title":"Rational excipient selection for co-amorphous formulations","volume":"14","author":"Korhonen","year":"2017","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.07.016_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2018.06.007","article-title":"Permeability of glibenclamide through a PAMPA membrane: the effect of co-amorphization","author":"Ruponen","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0095","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1039\/b715396a","article-title":"Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine","volume":"10","author":"Childs","year":"2008","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ejpb.2018.07.016_b0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1211\/jpp.59.3.0006","article-title":"Characterisation of blends of paracetamol and citric acid","volume":"59","author":"Hoppu","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.07.016_b0105","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/cg401673z","article-title":"Mechanochemical reaction of sulfathiazole with carboxylic acids: formation of a cocrystal, a salt, and coamorphous solids","volume":"14","author":"Hu","year":"2014","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2018.07.016_b0110","article-title":"Drug-excipient interactions: effect on molecular mobility and physical stability of ketoconazole-organic acid coamorphous systems","author":"Fung","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0115","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.8b00035","article-title":"physical stability and dissolution behavior of ketoconazole-organic acid coamorphous systems","volume":"15","author":"Fung","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejpb.2016.10.002","article-title":"Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen\/indomethacin","volume":"109","author":"Beyer","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jphp.12458","article-title":"Preparation and characterization of spray-dried co-amorphous drug\u2013amino acid salts","volume":"68","author":"Jensen","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.07.016_b0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/pharmaceutics6030416","article-title":"Improving co-amorphous drug formulations by the addition of the highly water soluble amino acid, proline","volume":"6","author":"Jensen","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2018.07.016_b0135","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1021\/acs.cgd.5b00349","article-title":"Coamorphous lurasidone hydrochloride\u2013saccharin with charge-assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with pH-independent solubility behavior","volume":"15","author":"Qian","year":"2015","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2018.07.016_b0140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1208\/s12249-008-9055-7","article-title":"Carvedilol: solubilization and cyclodextrin complexation: a technical note","volume":"9","author":"Loftsson","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.07.016_b0145","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/qua.10362","article-title":"Substituent effects on the electronic structure and pKa of benzoic acid","volume":"90","author":"Hollingsworth","year":"2002","journal-title":"Int. J. Quantum Chem."},{"key":"10.1016\/j.ejpb.2018.07.016_b0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.fluid.2009.09.022","article-title":"Extraction of aqueous of malic acid by trioctylamine extractant in various diluents","volume":"287","author":"Uslu","year":"2010","journal-title":"Fluid Phase Equilib."},{"key":"10.1016\/j.ejpb.2018.07.016_b0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000104796","article-title":"Effect of addition of citric acid and casein phosphopeptide-amorphous calcium phosphate to a sugar-free chewing gum on enamel remineralization in situ","volume":"41","author":"Cai","year":"2007","journal-title":"Caries Res."},{"key":"10.1016\/j.ejpb.2018.07.016_b0160","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600680523","article-title":"Thermal characterization of citric acid solid dispersions with benzoic acid and phenobarbital","volume":"68","author":"Timko","year":"1979","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.07.016_b0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.xphs.2017.09.024","article-title":"coamorphous active pharmaceutical ingredient-small molecule mixtures: considerations in the choice of coformers for enhancing dissolution and oral bioavailability","volume":"107","author":"Newman","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.07.016_b0170","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1208\/s12249-016-0616-x","article-title":"Pharmaceutical salts of carvedilol: polymorphism and physicochemical properties","volume":"18","author":"Hiendrawan","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.07.016_b0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/mp0601345","article-title":"The salt\u2212 cocrystal continuum: the influence of crystal structure on ionization state","volume":"4","author":"Childs","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2018.07.016_b0180","series-title":"Spectrometric Identification of Organic Compounds","first-page":"95","author":"Silverstein","year":"2014"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118302807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118302807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:31:28Z","timestamp":1760545888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118302807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":36,"alternative-id":["S0939641118302807"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.07.016","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organic acids as co-formers for co-amorphous systems \u2013 Influence of variation in molar ratio on the physicochemical properties of the co-amorphous systems","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}